Crewe Advisors LLC Buys 110 Shares of The Allstate Co. (NYSE:ALL)

Crewe Advisors LLC boosted its position in shares of The Allstate Co. (NYSE:ALLFree Report) by 5.1% during the 3rd quarter, HoldingsChannel reports. The fund owned 2,282 shares of the insurance provider’s stock after buying an additional 110 shares during the quarter. Crewe Advisors LLC’s holdings in Allstate were worth $433,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in the company. Northwest Investment Counselors LLC bought a new position in shares of Allstate during the 3rd quarter worth about $28,000. Catalyst Capital Advisors LLC bought a new position in Allstate during the third quarter worth about $29,000. Versant Capital Management Inc lifted its stake in Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 78 shares during the period. Family Firm Inc. bought a new stake in shares of Allstate in the 2nd quarter valued at approximately $38,000. Finally, MCF Advisors LLC raised its holdings in shares of Allstate by 33.9% in the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after buying an additional 84 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Trading Up 0.2 %

ALL stock opened at $203.80 on Friday. The company has a quick ratio of 0.40, a current ratio of 0.40 and a debt-to-equity ratio of 0.43. The Allstate Co. has a twelve month low of $134.17 and a twelve month high of $205.35. The company has a market cap of $53.97 billion, a P/E ratio of 13.20, a PEG ratio of 1.81 and a beta of 0.48. The business has a fifty day moving average of $191.41 and a 200-day moving average of $177.84.

Allstate (NYSE:ALLGet Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analysts’ expectations of $14.57 billion. Allstate had a return on equity of 26.67% and a net margin of 6.77%. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same period in the previous year, the business posted $0.81 EPS. As a group, equities research analysts expect that The Allstate Co. will post 16.07 EPS for the current year.

Allstate Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th will be paid a $0.92 dividend. The ex-dividend date is Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a yield of 1.81%. Allstate’s payout ratio is presently 23.83%.

Insiders Place Their Bets

In other news, insider John E. Dugenske sold 36,367 shares of the firm’s stock in a transaction on Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the transaction, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. This trade represents a 57.06 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently commented on ALL shares. BMO Capital Markets boosted their price target on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research note on Friday, October 18th. Roth Mkm reaffirmed a “buy” rating and issued a $200.00 target price on shares of Allstate in a report on Wednesday, August 14th. Barclays lifted their price target on shares of Allstate from $175.00 to $187.00 and gave the company an “underweight” rating in a report on Thursday, October 31st. JPMorgan Chase & Co. upped their price objective on shares of Allstate from $205.00 to $207.00 and gave the stock an “overweight” rating in a research note on Thursday, October 10th. Finally, Bank of America lifted their target price on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $214.19.

View Our Latest Report on ALL

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.